Price Alert

Maravai LifeSciences Inc... (MRVI)

NASDAQ: MRVI · Real-Time Price · USD

2.67

-0.12 (-4.30%)

At close: Sep 12, 2025, 3:59 PM

2.67

0.00%

After-hours: Sep 12, 2025, 04:57 PM EDT

Maravai LifeSciences Statistics

Share Statistics

Maravai LifeSciences has 142.75M shares outstanding. The number of shares has increased by -44.22% in one year.

Shares Outstanding	142.75M
Shares Change (YoY)	-44.22%
Shares Change (QoQ)	-2.06%
Owned by Institutions (%)	89.72%
Shares Floating	103.37M
Failed to Deliver (FTD) Shares	4,221
FTD / Avg. Volume	0.27%

Short Selling Information

The latest short interest is 13.5M, so 9.33% of the outstanding shares have been sold short.

Short Interest	13.5M
Short % of Shares Out	9.33%
Short % of Float	11.08%
Short Ratio (days to cover)	6.96

Valuation Ratios

The PE ratio is -5.19 and the forward PE ratio is -13. Maravai LifeSciences's PEG ratio is -0.31.

PE Ratio	-5.19
Forward PE	-13
PS Ratio	2.9
Forward PS	3.5
PB Ratio	2.31
P/FCF Ratio	-33.87
PEG Ratio	-0.31

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Maravai LifeSciences.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.53, with a Debt / Equity ratio of 1.16.

Current Ratio	7.53
Quick Ratio	6.65
Debt / Equity	1.16
Debt / EBITDA	-2.4
Debt / FCF	-16.97
Interest Coverage	-4.94

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$454.71K
Profits Per Employee	$-254.12K
Employee Count	570
Asset Turnover	0.26
Inventory Turnover	3.01

Taxes

Income Tax	-1.86M
Effective Tax Rate	0.71%

Stock Price Statistics

The stock price has increased by -68.18% in the last 52 weeks. The beta is 0.29, so Maravai LifeSciences's price volatility has been higher than the market average.

Beta	0.29
52-Week Price Change	-68.18%
50-Day Moving Average	2.5
200-Day Moving Average	3.21
Relative Strength Index (RSI)	62.88
Average Volume (20 Days)	1,561,053

Income Statement

In the last 12 months, Maravai LifeSciences had revenue of 259.19M and earned -144.85M in profits. Earnings per share was -1.05.

Revenue	259.19M
Gross Profit	108.31M
Operating Income	-235.62M
Net Income	-144.85M
EBITDA	-156.92M
EBIT	-213.78M
Earnings Per Share (EPS)	-1.05

Full Income Statement

Balance Sheet

The company has 322.4M in cash and 376.69M in debt, giving a net cash position of -54.29M.

Cash & Cash Equivalents	322.4M
Total Debt	376.69M
Net Cash	-54.29M
Retained Earnings	140.89M
Total Assets	896.97M
Working Capital	290.08M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.46M and capital expenditures -29.66M, giving a free cash flow of -22.19M.

Operating Cash Flow	7.46M
Capital Expenditures	-29.66M
Free Cash Flow	-22.19M
FCF Per Share	-0.16

Full Cash Flow Statement

Margins

Gross margin is 41.79%, with operating and profit margins of -90.91% and -55.89%.

Gross Margin	41.79%
Operating Margin	-90.91%
Pretax Margin	-100.89%
Profit Margin	-55.89%
EBITDA Margin	-60.54%
EBIT Margin	-90.91%
FCF Margin	-8.56%

Dividends & Yields

MRVI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for MRVI is $5, which is 87.3% higher than the current price. The consensus rating is "Hold".

Price Target	$5
Price Target Difference	87.3%
Analyst Consensus	Hold
Analyst Count	9

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	0.31
Piotroski F-Score	3